Clinical Trial Update: Efficacy of Ciclesonide Inhaled Once Daily Versus Other Corticosteroids Used for Treatment of Mild Asthma in Children (4 to 11 Years) (BY9010/CA-101) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated daily inhaled ciclesonide versus other corticosteroids for mild asthma in children aged 4 to 11; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Ciclesonide inhaled (ciclesonide)
• Other corticosteroids (corticosteroids)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2010-12-22